3//SEC Filing
CHP II LP 3
Accession 0001209191-04-028927
CIK 0001178670other
Filed
May 31, 8:00 PM ET
Accepted
Jun 1, 6:54 PM ET
Size
6.9 KB
Accession
0001209191-04-028927
Insider Transaction Report
Form 3
CHP II LP
10% Owner
Holdings
Series A Convertible Preferred Stock
→ Common Stock (526,315 underlying)Series B Convertible Preferred Stock
→ Common Stock (1,284,210 underlying)Series C Convertible Preferred Stock
→ Common Stock (48,843 underlying)
Footnotes (3)
- [F1]Automatically converts into common stock upon the closing of the issuer's initial public offering of common stock.
- [F2]N/A
- [F3]Reflects a 1-for-1.9 reverse stock split, which became effective on May 7, 2004, pursuant to which each share of Series A, B and C Preferred Stock will automatically convert into approximately 0.53 shares of common stock upon the closing of the issuer's initial public offering of common stock.
Documents
Issuer
ALNYLAM PHARMACEUTICALS INC
CIK 0001178670
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001114499
Filing Metadata
- Form type
- 3
- Filed
- May 31, 8:00 PM ET
- Accepted
- Jun 1, 6:54 PM ET
- Size
- 6.9 KB